Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Arch Immunol Ther Exp (Warsz) · 2018 · PMC6154007 · PMID 29744553

Europe PMC DOI

hedged sentence

0.3800

closest p · 7.6× alpha

0.3800

boldest claim

The sentences

a negative trendp = 0.38not close (p > 0.1)

Of note, we observed that delta CRP revealed even a negative trend with delta DAS28 ( p = 0.38, r = − 0.30) (Fig. 4 b) and delta miRNA-5196 ( p = 0.42, r = − 0.28) (Fig. 4 c).

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.